| Valid Data Submission Method(s) | Measure Type | High Priority Measure? | NQS Domain | Specialty Measure Sets |
|---|---|---|---|---|
| Claims, Registry | Process | Yes | Effective Clinical Care | Hospitalists |
Measure Description
Percentage of patients with sepsis due to MSSA bacteremia who received beta-lactam antibiotic (e.g. nafcillin, oxacillin or cefazolin) as definitive therapy
Instruction
This measure is to be reported each episode a patient is hospitalized with sepsis due to MSSA bacteremia during the performance period. This measure may be reported by eligible clinicians who perform the quality actions described in the measure based on the services provided and the measure-specific denominator coding.y
Denominator
All hospitalized patients with sepsis due to MSSA bacteremia
DENOMINATOR NOTE: A patient 18 years or older who has an initial inpatient encounter with symptoms of bacteremia that is documented of being methicillin-susceptible Staphylococcus aureus.
Denominator Criteria (Eligible Cases):
All patients 18 years or older
AND
Diagnosis for Sepsis due to MSSA (ICD-10-CM): A41.01
AND
Patient encounter during performance period (CPT): 99218, 99219, 99220, 99221, 99222, 99223, 99231, 99232, 99233, 99234, 99235, 99236, 99291
Numerator
Number of denominator eligible patients treated with a beta-lactam antibiotic (e.g. nafcillin, oxacillin or cefazolin) as definitive therapy
Definition:
Beta-Lactam – For the purposes of this measure, a beta-lactam antibiotic is defined as Nafcillin, Oxacillin or Cefazolin
Numerator Options:
Performance Met: Patient treated with a beta-lactam antibiotic as definitive therapy (G9558)
OR
Denominator Exception: Documentation of medical reason(s) for not prescribing a Beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics) (G9559)
OR
Performance Not Met: Patient not treated with a beta-lactam antibiotic as
definitive therapy, reason not given (G9560)